SECRETIN IS AN INEFFECTIVE TREATMENT FOR PERVASIVE DEVELOPMENTAL DISABILITIES. A REVIEW OF 15 DOUBLE-BLIND RANDOMIZED CONTROLLED TRIALS
Saved in:
STURMEY, P., SECRETIN IS AN INEFFECTIVE TREATMENT FOR PERVASIVE DEVELOPMENTAL DISABILITIES. A REVIEW OF 15 DOUBLE-BLIND RANDOMIZED CONTROLLED TRIALS. Research in Developmental Disabilities, Vol. 26, no. 1 (2005), p. 87-97.
Ref.
131117
Location:
SIIS R.775 Archivo
Palabras clave:
Ceguera, Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Literatura científica, Tratamiento médico
Ceguera, Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Literatura científica, Tratamiento médico
Similar Items: SECRETIN IS AN INEFFECTIVE TREATMENT FOR PERVASIVE DEVELOPMENTAL DISABILITIES. A REVIEW OF 15 DOUBLE-BLIND RANDOMIZED CONTROLLED TRIALS
- MULTISITE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PORCINE SECRETIN IN AUTISM
- RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF MODAFINIL FOR THE TREATMENT OF METHAMPHETAMINE DEPENDECE
- EFFECTS OF ORAL METHAMPHETAMINE ON COCAINE USE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
- DOUBLE-BLIND RANDOMIZED MULTICENTRE TRIAL OF ACAMPROSATE IN MAINTAINING ABSTINENCE FROM ALCOHOL
- DOUBLE-BLIND RANDOMIZED TRIAL OF BUPRENORPHINE AND METHADONE IN OPIATE DEPENDENCE
- NEFAZODONE IN OUT-PATIENT TREATMENT OF INHALED COCAINE DEPENDENCE: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL